Ulka Vaishampayan
@drulkav
Followers
99
Following
86
Media
8
Statuses
189
Joined April 2023
Congrats @alexzhuDO looking forward to collaborating with u in swog and the world of RCC. @UMich @rogel cancer center
So proud of amazing mentee @alexzhuDO co-mentored by @JLWrightMD @uwurology for his accomplishments as a fellow & his new job @cityofhope with brilliant @montypal @TDorffOnc @AbhiTrip87 et al. We are launching an investigator initiated trial @fredhutch that Alex led the protocol!
0
0
0
My thoughts on ESMO data Neoadjuvant enfortumab +pembro has an amazing 57% pCR rate and improved EFS and OS. However not compared to chemo. control arm is no systemic therapy. After pCR is post op therapy is needed. Can ctDNA be used as a guide?
0
0
0
True @neerajaiims is a star himself and sheds light on others.
I am grateful and proud to be a long standing friend and mentee of @neerajaiims — he has blessed my life and career often. Thanks for all you do for me and others
0
0
3
Congrats @DrYukselUrun and @neeraj agarwal md For a successful meeting
Terrific talk by @DrYukselUrun in New Delhi at #GUOncocon25 👉1st line therapy selection of mRCC #kidneycancer 👇What to do after adjuvant pembro? & Highlighted body of work by @DrChoueiri @montypal @NazliDizman @tompowles1 @Garg_H
0
2
8
Congrats @jason Abel
Incredible surgeon, scientist, father and mentor…and he’s too humble to admit it so I will! So happy to see @ejasonabel get this well deserved award. @wiscurology @UWCarbone @WiscUroOnc
0
0
0
Congrats@ASTRO @SameerKeoleMD
Welcome to Day 2 of #ASTRO25! Watch this welcome video from ASTRO President Sameer Keole, MD, to hear about exciting events happening on Sunday, September 28 at ASTRO's 2025 Annual Meeting. @SameerKeoleMD
0
0
0
Brilliant idea for a forward thinking session. We r all doing this and getting creative with RT applications. Now let’s collect some trial evidence of how to optimize this!
EDU-01 There is a reason we marked @drdavidpalma’s session with this. This is an educational session that I personally asked Dr. Palma to deliver. It is the essence of the meeting. How will our field expand? This is one way. Don’t miss it!
0
0
2
Agree may as well use the skills we have
Today a pt asked me why are you doing a physical exam (majority of docs dont do i ) when I just got a CT scan I am old school No test is 100 % accurate Radiologist are also humans and can miss things Curious to see what other Med Oncs do ? @OncBrothers
0
0
1
Impressive and insightful!
🚨🧬 Hot off the press! Pleased to share our commentary in @ASCO Journal of Clinical Oncology @JCO_ASCO in the Comments & Controversies section👉 "Precision Oncology and Modernizing Evidence Standards: A Critical Commentary on the Cochrane Review" @Dr_R_Kurzrock @ASCOPost 👉Why
0
2
2
Impressed with the consensus conference. @AlanBryce9 @NeerajAgarwal
Just started👉2025 United States #ProstateCancer Consensus Conference (USPCCC) 👉with @AlanBryce9 ‘s introductory remarks. @philkuo @cityofhope debating for PSMA PET for treatment selection. Caveat👉 Medical conditions with false positive PSMA PET lesions 👇@urotoday @PCFnews
0
0
4
Honored to co chair a clinical trials session at IKCS25 looking forward to the sessions education and research blend with latest and greatest I. Kidney cancer
Honored to co-chair IKCS25 in Denver CO with @spsutkaMD @mkbupathi , abst deadline Aug15, great agenda put together with @QingZhangLab @bergsa83 @ChadTangMD #MCarlo #DGeynisman @salvolarosa @KidneyCancer plz submit abst
1
4
13
Congrats @neerajaiims and team. Exciting results in this publication
Just came online in @TheLancet 👉Our two papers on improved OS with Enzalutamide + Talazoparib in mCRPC #ProstateCancer in all-comer & HRRm patients (Median OS and HRs👇). Weblinks to the papers👉 https://t.co/AMqlUvlkNG and https://t.co/W8gO8lWxQo
@PCFnews @urotoday @OncoAlert
0
0
2
Excellent commentary with key points
⚠️ The missing subplot in #KEYNOTE689 🧠💉 Yes, periop #pembrolizumab improved EFS in resectable LA-HNSCC. But what about crossover? 🧩 Not allowed. 📉 Post-progression therapy not reported. In a post–#KEYNOTE048 world, that’s a problem. 💣 Why it matters: No ICI for progressing
0
0
0
This is a FREE event, open to anyone who would like to join us!
us02web.zoom.us
Zoom is the leader in modern enterprise video communications, with an easy, reliable cloud platform for video and audio conferencing, chat, and webinars across mobile, desktop, and room systems. Zoom...
0
5
5
Do not miss the famous and talented researcher @KimrynRathmell prior NCI director speaking about kidney cancer!
🎉 We're so excited to have @KimrynRathmell @OSUCCC_James join us in conversation during the KCA's Women in RCC summer webinar next month! 👉Register today: https://t.co/rCPWlwNNGk
0
2
6
VEGF and HIF combo synergy noted
@brian_rini @BReinfeld @tompowles1 @DrChoueiri @montypal @PGrivasMDPhD @kidneycan @KidneyCancer @KidneyCancerDoc @HHammersMD Seems to me that toxicity for cas + Cabo seemed more favorable but hard to interpreted in single atm trial
0
0
0
Congratulations @DrChoueiri U have helped so many! Continue the impressive work! Best wishes
Congratulations @DrChoueiri , a mentor who has become family on receiving the Waun Ki Hong Outstanding Achievement Award! Your work has transformed so many lives. Wishing I could be there to celebrate this so well deserved honor!
0
0
2
A paper highlighting the contemporary role of cytoreductive nephrectomy in met RCC. Consider PROBE trial. https://t.co/GETr5xzaCz
0
0
0
Congrats @PGrivasMDPhD
Congratulations to my dear friend @PGrivasMDPhD and to the @JCO_ASCO associate editor Thomas E. Stinchcombe!! @ASCO
1
0
1